Trial site
Centrum Medyczne Angelius Provita
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)7 trials
- Alopecia areata2 trials
- Psoriasis2 trials
- Chronic rhinosinusitis with nasal polyps1 trial
- Chronic spontaneous urticaria1 trial
- Phase
- Phase 37 trials
- Phase 24 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer5 trials
- Eli Lilly and Company2 trials
- Amgen1 trial
- Celldex Therapeutics Inc.1 trial
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Recruiting
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)2 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Chronic spontaneous urticaria1 recruiting
Closed trials
Completed
Completed
A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
Terminated
Completed
Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis
Terminated
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026